John G. Cooper
Independent DirectorMr. John G. Cooper, C.P.A., has been an Independent Director of Rockwell Medical, Inc. since September 7, 2017. Mr. Cooper is the Founder and Principal of JGC Advisors. He is an experienced executive with managing publicly-traded companies in the life sciences industry. He serves on the Strategic Advisory Board of IC Surgical, Incorporated and Oxidien Pharmaceuticals, Incorporated. He has played key leadership roles with companies developing and commercializing important medical technologies, including the first FDA approved synthetic peptide-containing pulmonary surfactant for premature infants with severe respiratory disease, the application of transgenic technology for developing bio-therapeutics and specialty drug development services and the second FDA approved blood diagnostic test for HIV. Mr. Cooper has expertise in corporate and financial management with expertise in capital raising, mergers and acquisitions, strategic alliances, organizational development and board governance for public life science companies. Over his career, Mr. Cooper has raised approximately 1 billion in capital through various financing and strategic transactions. Mr. Cooper is providing financial and management advisory services to Life Science companies. From 2001 to 2016, Mr. Cooper was an Senior Executive for Windtree Therapeutics, Inc. (formerly Discovery Laboratories, Inc.), a specialty pharmaceutical company and served as President, Chief Executive Officer and Board Member from 2013 to 2016, President and Chief Financial Officer from 2010 to 2013 and Executive Vice President and Chief Financial Officer from 2002 to 2010 and Senior Vice President and Chief Financial Officer from 2001 to 2002. Previously, Mr. Cooper was Senior Vice President and Chief Financial Officer at Chrysalis International Corporation (acquired by Phoenix International Life Sciences Inc.), DNX Corporation and served in senior financial management roles at ENI Diagnostics, Inc. (acquired by Pharmacia AB). Mr. Cooper earned a Certified Public Accountant credential in 1985 and a Bachelor of Science degree in Commerce from Rider University in 1980. He previously served as a financial analyst at CR Bard, Inc., a public medical device company. Chrysalis International Corporation was a public company providing drug development services to the biopharmaceutical industry. DNX Corporation was a public life sciences company pioneering transgenic technology for xenotransplantation and biotherapeutic development. ENI Diagnostics, Inc. developed and commercialized the second FDA-approved blood diagnostic test for HIV.
Positions
- Company NameRockwell Medical, Inc.Stock CodeRMTIPositionIndependent DirectorColleagues
- MSMark StrobeckPresident, CEO & Director
- RSRobert Samuel RadieIndependent Chairman
- JNJesse NeriSenior VP & CFO
- MCMegan C. TimminsExecutive VP, Chief Legal Officer & Secretary
- HHHeather H. HunterSenior VP & COO
- NFNicholas FanslauController & Principal Accounting Officer
- ARAllen Richard NissensonIndependent Director
- JMJoan M. LauIndependent Director
